Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Infusion Pump vs Single Shot Peripheral Block for Post-op Pain in Orthopaedic Surgery
NCT07349810Phase 4Recruiting
- Sponsor
- Rutgers University
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Rutgers University. Started Jan 2026; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07349810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349810.